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ABSTRACT
Previous dosimetric studies during photodynamic therapy
(PDT) of superficial lesions within a cavity such as the
nasopharynx, demonstrated significant intra- and interpatient
variations in fluence rate build-up as a result of tissue surface
re-emitted and reflected photons, which depends on the opti-
cal properties. This scattering effect affects the response to
PDT. Recently, a meta-tetra(hydroxyphenyl)chlorin-mediated
PDT study of malignancies in the paranasal sinuses after sal-
vage surgery was initiated. These geometries are complex in
shape, with spatially varying optical properties. Therefore,
preplanning and in vivo dosimetry is required to ensure an
effective fluence delivered to the tumor. For this purpose,
two 3D light distribution models were developed: first, a sim-
ple empirical model that directly calculates the fluence rate
at the cavity surface using a simple linear function that
includes the scatter contribution as function of the light
source to surface distance. And second, an analytical model
based on Lambert’s cosine law assuming a global diffuse
reflectance constant. The models were evaluated by means of
three 3D printed optical phantoms and one porcine tissue
phantom. Predictive fluence rate distributions of both models
are within  20% accurate and have the potential to deter-
mine the optimal source location and light source output
power settings.
INTRODUCTION
The clinical response to meta-tetra(hydroxyphenyl)chlorin (m-
THPC, Foscan)-mediated photodynamic therapy (PDT) of head
and neck malignancies depends partially on the fluence rate and
fluence, that is, light dose delivered to the target and risk areas.
Studies have demonstrated that an excessive or conversely insuf-
ficient fluence rate will both result in a reduced cell response and
insufficient degradation of the tumor (1–5). An excessive fluence
rate will cause depletion of the photosensitizer and/or the oxygen
in the tissue (4,6,7). Insufficient fluence rate will negatively
affect the phototoxic reactions within the cell (1–3,6,7). High flu-
ence rates may cause adverse reactions such as extensive edema,
severe mucositis, increased pain perception, unintended necrosis
and hyperthermia (1–3,5,8–10). A low fluence rate requires an
extended illumination time to achieve an effective light dose (1–
10). It is widely accepted that an empirically determined light
dose of 20 Jcm2 at a fluence rate of 100 mWcm2
(k = 652nm) to the target area results in an optimal response to
m-THPC (dose 0.15 mg kg1 body weight)–mediated PDT of
the head and neck area (11–18).
For easily accessible superficial lesions in the head and neck
region, such as the floor of mouth, dosimetry is relatively
straightforward. In these cases, for a given target area radius,
assuming the spot is aimed onto the surface at a perpendicular
angle, the distance of the microlens tip to the target area, along
with the total source output power (W) can be calculated in order
to deliver a homogeneous spot of 100 mWcm2 for 200 s. The
organs at risk are shielded with red light absorbing cloth or black
wax during the illumination. For less accessible superficial
lesions such as oropharyngeal walls or base of tongue, a cylindri-
cal balloon with a linear diffuser in its center is often employed
(17,19). The length of the linear diffuser corresponds to the
length of the lesion and its output power is set to generate an
incident fluence rate of 100 mWcm2 at the surface of the bal-
loon. For lesions in the nasopharynx, a dedicated light delivery
applicator was developed to shield the soft palate and nasal cav-
ity while allowing full efficient light coverage of the nasopharyn-
geal cavity (20).
Recently, we have reported m-THPC–mediated PDT in recur-
rent or residual malignant tumors of the sinonasal cavity (21).
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These tumors can persist or recur despite treatment with surgery
and/or (chemo) radiation. The vicinity of essential structures,
combined with treatment-associated high morbidity risks, limits
alternative treatment options, such as salvage surgery and/or reir-
radiation. Chemotherapy in these patients is not curative. Intra-
cavity PDT demonstrated to be a feasible adjuvant therapy after
surgical debulking to achieve local tumor control without the
severe adverse effects associated with aforementioned conven-
tional treatment options (21,22). However, achieving a repro-
ducible and controlled dosimetric approach remained
cumbersome. In the pilot study of Caesar et al., the light delivery
was based on the total output power of the light source, using
either a microlens, a linear diffuser, or a spherical bulb diffuser
at certain distance to the target area, aiming a direct incident
light term of 100 mWcm2 (21). The optimal source location
was estimated preoperatively using 2D computed tomography
(CT) and magnetic resonance (MR) images. The source was
manually positioned and manually kept at this location, verified
under endoscopic guidance. The fluence rate at the target area
was monitored using multiple isotropic detectors connected to a
dosimetry device (21–23). The laser was then activated and the
illumination lasted until a cumulative light dose of 20 Jcm2
was measured. Analysis of in vivo fluence rate measurements
during sinonasal PDT showed substantial spatial and temporal
variations within and between patients (T.E.M. van Doeveren
et al., unpublished data). These variations may have a profound
impact on the clinical response and clearly demonstrate the
necessity for a standardized and reproducible dosimetric
approach. The current approach lacks accurate positioning of the
source, reproducibility and 3D light dosimetry planning.
Dosimetry planning and in vivo fluence rate measurements for
intracavity PDT are necessary because of the integrating sphere
effect that occurs when optically irradiating the inner surface of
a hollow tissue geometry, like the bladder (24). Photons that are
emitted from the source enter the tissue at the boundary after
which they are subjected to absorption and scattering events. A
portion of these photons will be backscattered into the cavity
and re-enter the tissue at a different location inside the cavity,
resulting in a fluence rate build-up. The fluence rate at the tissue
surface will be higher than the nonscattered light, that is, direct
incident term emanating from the source. The amount of light
that is backscattered depends on the tissue optical properties such
as the scatter function, absorption and scattering coefficient. This
build-up in fluence rate will influence the amount and rate of the
photosensitizer activation and thus has the potential to alter the
clinical response. This integrating sphere effect has been
observed in several dosimetric PDT studies (3,10,17,20,24–32).
For example, van Veen et al. demonstrated a fluence rate build-
up of up to 4.5 times higher than the nonscattered direct incident
light term from the source during m-THPC–mediated PDT of the
nasopharynx (30). Quon et al. observed a build-up factor of 5
times during transoral robotic surgery (TORS)-guided PDT of
the oropharynx (17).
Hollow cavities such as the esophagus or trachea can be
described as cylinders, or in case of the bladder as an ellipsoidal
shape, which allows a straightforward dosimetric fluence rate dis-
tribution planning approach, based on surface area and total out-
put power (10,24,26). However, the hollow defect that remains
after salvage surgery of the sinonasal cavity is complex in geom-
etry and varies in volume and surface area between patients.
These geometries cannot be simply approximated by a well-
defined shape such as a hollow cylinder or sphere but require a
more dedicated approach. In addition, the optical properties vary
within the geometry and between patients (33–37).
The primary aim of this study is to develop light dosimetry
models, allowing reliable calculations of the fluence rate at the
surface of these complex sinonasal cavities while taking tissue
backscattering into account. The goal is to develop two simple,
fast and easily applicable dosimetry tools that merely require a
3D reconstructed model from CT image data and a series of pre-
PDT patient optical measurements that enables calculation of the
fluence rate including the scatter contribution.
For this purpose, three 3D printed optical phantoms of sinona-
sal cavities of patients who have undergone surgical resection of
a sinonasal malignancy were constructed. The optical properties
of the print material (Acrylonitrile Butadiene Styrene (ABS)) are
approximately those of human mucosal tissue (20,38) with
respect to the scattering coefficient. In addition, a clinically more
relevant porcine tissue phantom was developed. Dosimetry
experiments were conducted on these phantoms using a spherical
diffuser and multiple isotropic detectors. Diffuse reflectance spec-
troscopy (DRS) was used to determine the phantom’s optical
properties. From these results, an empirical 3D light distribution
model was established. Secondly, an analytical model was devel-
oped. The analytical model is based on diffuse Lambertian
reflectance and is initially used to validate the reliability of the
empirical model (39). Both models are based on the specific
sinonasal geometry obtained from CT image data.
MATERIALS AND METHODS
Two 3D light distribution models were developed: an empirical model
derived from the phantom’s fluence rate data, and an analytical model
based on the phantom’s optical properties. The input variables of the
empirical model are, first, the build-up factor function b (r), where r is
the distance between the source and detector/cavity surface. Second, the
total output power of the spherical bulb diffuser Pout (mW) and third, a
high-resolution 3D patient-specific surfaces mesh, consisting of triangular
faces and vertices (~10.000 faces, ~1.3 mm2 per face). The input
variables of the analytical model, which is based on Lambertian cosine
law, are the medium’s diffuse reflectance coefficient Rd, the same mesh
surface as the empirical model and the total output power of the
spherical bulb diffuser Pout (mW). Both models were developed in
MATLABTM (MATLAB, MathWorks Inc., MA). To evaluate both
models, three 3D printed ABS optical phantoms and a separate porcine
tissue phantom were constructed. The validity of both, the analytical
model and the empirical model, was evaluated by comparing the actual
fluence rate as measured in the ABS optical phantoms and the porcine
tissue phantom, with the calculated fluence rate at eight different
measurement locations. A flowchart of the research methodology is
depicted in Fig. 1.
ABS optical phantoms. The fluence rate at the inner surface of a
cavity depends on the geometry and optical properties. For this study,
only the influence of the geometry is investigated. Three solid phantoms
were printed in white ABS (Materialise, Leuven, Belgium). The optical
properties, with respect to the reduced scattering coefficients,
approximate that of tissue and were determined by three sequential
spatially resolved DRS measurements on a solid bulky section of the
phantom (40). In addition, DRS measurements were performed on a
volunteer’s oral buccal mucosa. An average reduced scattering coefficient
(ls0) at k = 652 nm was determined to be 8.6 cm
1 for ABS white and
12.8 cm1 for oral buccal mucosal tissue. An average absorption
coefficient (la) at k = 652 nm was 0.01 cm
1 for ABS white and
0.12 cm1 for oral buccal mucosal tissue. The possible consequences of
the difference in optical properties are discussed later in the manuscript.
Postoperative CT data of three different representative patients: that is,
eligible for sinonasal PDT, who had undergone sinonasal salvage surgery
were selected. The geometry of the 3D ABS optical phantoms was
obtained using Hounsfield threshold segmentation to separate air from
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tissue in 3D slicer (41). Tissue and bony structures were considered to be
equal, which means that no layered structures were incorporated. The
minimal distance between the inner surface of the sinonasal cavity and
the exterior surface of the phantom was set to be 2 cm, thereby minimiz-
ing the possible contribution of backscattering from the exterior boundary
into the cavity, as well as loss to the external space. The volume and the
total cavity surface area were determined for all three ABS optical phan-
toms.
After printing the ABS optical phantoms, a total of eight 1-mm-outer
diameter (OD) holes were drilled externally into the cavity, entering the
cavity on various locations of interest. These holes facilitate the passage
and positioning of the isotropic detectors (spherical tip OD 0.85 mm,
model IP85; Medlight S.A., Ecublens, Switzerland) into the cavity. The
phantoms were printed in two separate adjacent parts through the middle
of the sagittal plane, to allow visual verification regarding the positioning
of the eight isotropic detectors and the spherical bulb diffuser. Rendering
of the ABS optical phantom is shown in Fig. 2.
The spherical tip of the isotropic detector was positioned directly
above the surface of the cavity. For this study, only the spherical bulb
diffuser (Medlight SA, Ecublens, Switzerland) was used as the PDT
light source. The spherical bulb diffuser was connected to a 2 W diode
laser (Ceralas PDT, Biolitec, Bonn, Germany) emitting at k = 652 nm.
The diffuser was positioned in the center of the cavity (slightly poste-
rior) and pulled back ~10 mm (anterior) toward the nostril through a
transparent Perspex tube. In total, 16 measurements per ABS optical
phantom were made. The isotropic detectors measure the fluence rate
by collecting the direct incident light (Einc) from the source, as well as
the diffuse scattered light from all incoming directions, that is,
/meas = Einc + (/sc + /bsc).
A cone beam CT (CBCT) was made of the complete ABS optical
phantom including the incorporated isotropic detectors and spherical
bulb diffuser at position. CBCT imaging was done for two spherical
bulb diffuser positions: an anterior (A) and a posterior (P) position.
From the 3D reconstructed CBCT images, the exact distance between
the center of the spherical bulb diffuser and the isotropic detectors was
determined. This distance was used to calculate the local build-up factor
b (r) at the position of the isotropic detector at the inner surface of the
cavity.
b ðrÞ ¼ /measðrÞPout
4pr2
  ð1Þ
where r (cm) represents the distance between the light source, that is, the
spherical bulb diffuser and the isotropic detector, Pout the total output
power of the source (mW), /meas (mWcm2) the measured fluence rate
and the denominator term expresses the direct incident term Einc. The b
(r) function was derived in each individual ABS optical phantom, using
all valid fluence rate measurements (i.e. the detectors that are exposed to
Einc, with the spherical bulb diffuser at two positions (A and P)). The
output power of the spherical bulb diffuser was set at 500 mW. The
empirical model will be derived from the dosimetry data for all ABS
optical phantoms and are therefore considered to be a result.
Porcine tissue phantom. The ex vivo porcine tissue phantom was
developed to mimic a more clinically relevant setting, that is, a higher la
as compared to the ABS optical phantom.
The porcine tissue phantom consists of a 3D printed shell, cloaked
inside with an average ~15 mm thick homogeneous layer of porcine mus-
cle tissue sutured and secured to the rigid mesh structure, thus creating a
tissue cavity that mimics sinonasal geometry. The 3D Voronoi mesh
structure was created in Autodesk Meshmixer. First, a simplified
slightly oversized sinonasal cavity shape was made. The shape was hol-
lowed and meshed in order to form a shell-like structure as can be seen
in Fig. 3.
Diffuse reflectance spectroscopy measurements were performed on the
porcine tissue. An average reduced scattering coefficient (ls0) at
k = 652 nm was determined to be 10.4 cm1, and the absorption coeffi-
cient (la) was 0.13 cm
1. The measured optical properties were similar
to buccal mucosa (ls0 = 12.8 cm
1 and la = 0.12 cm
1).
Infusion needles were used to guide the isotropic detectors to the
inner surface of the tissue cavity. A fixed rigid transparent Perspex tube
was used to guide and steadily position the spherical bulb diffuser to an
anterior and posterior position inside the cavity. The difference between
both source positions (sagittal plane) was approximately ~12 mm. The
same CBCT approach as used for the ABS optical phantoms was
employed to determine the exact distances between the center of the
spherical diffuser and the isotropic detectors. For each location, the local
build-up factor b was calculated. The output power of the spherical bulb
diffuser was 1500 mW.
Empirical model. The empirical model aims to calculate the fluence
(rate) at the surface of the cavity, that is, for all triangular faces using
a single linear equation that directly calculates the fluence rate
Figure 1. Flowchart of the conducted research. Three ABS optical phan-
toms and one porcine tissue phantom were constructed. DRS was used to
determine Rd from the la and ls’ results. A series of multiple fluence
measurements Φmeas (r) were performed on all four phantoms. An empir-
ical model was derived from the experimental fluence rate data, and an
analytical model was developed. After which both developed models
were used to simulate the 3D fluence rate distribution of all four phan-
toms. The simulation results were compared with the actual measure-
ments. Both models were compared and evaluated.
Figure 2. A rendering of the medial view of an ABS optical phantom
based on a patient who underwent an ethmoidectomy and sphenoidec-
tomy. The spherical bulb diffuser (in red) is placed at two different loca-
tions within the nasal cavity; the “A” anterior and “P” posterior position.
The white dots show the spherical tip of the isotropic detectors inside the
cavity.
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including the scatter terms. The model eventually should be able to
calculate the fluence rate distribution at the surface for all possible
source locations in order to find the optimal source location (OSL) at
which the target area is effectively illuminated during PDT, while
minimizing the light dose to the organs at risk. Computation speed is
therefore important.
The local build-up factor b (Eq. 1) was determined for all measure-
ment locations at the surface of the three ABS optical phantoms. The
aim was to investigate systemic behavior of b (r) in the arbitrary shaped
complex geometries. The cavity volume and surface area of the three
ABS optical phantoms were determined via the 3D meshes to investigate
their relation with b (r). Shadow areas or niches in the cavity, that is,
faces that are not directly in the line of sight with the source, were
excluded from the empirical model.
Analytical model. The developed analytical model assumes Lamberts
cosine law, that is, the incident radiant intensity of light emanating from
an ideal diffuse light emitting source and is directly proportional to the
cosine of the angle h between the direction of the incidence (from
incident surface to emitting source) and the surface normal of the
emitting source. The diffuse reflectance constant Rd determines the
fraction of incident light that is Lambertian being re-emitted from the
surface back into the cavity. The model first calculates the direct
irradiance, that is, “direct incident fluence rate” term Einc for each face.
Secondly, each face re-emits a part of the light, which is not absorbed,
back into the cavity, contributing to the fluence rate of other faces.
Therefore, photons will travel from the light source to the first face,
toward the second, toward the third, etc. until a certain amount of
reflections, at which the total amount of light is below 1% to that emitted
by the source. In summary, the fluence rate at the surface of a single face
is comprised of a direct incident term Einc (Eq. 2), a diffuse re-emitted
term (/bsc) and a diffuse incident term (/sc). The total diffuse scattered
term including the direct incident term (Einc) gives the fluence rate at the
surface (/face, tot). /face, tot = Einc + (/bsc + /sc).
Einc ¼ PoutCos ðhÞ
4p vsok k2
finc ð2Þ
where Einc is the irradiance due to direct incident light from the light
source, vsok k the magnitude of vector vso, that is, the distance between
the source and the center of the face, and finc the fraction of initial light
reaching the face, for example, located at the shadow boundaries. finc is
either 1, 2/3, 1/3 or 0, depending on the amount of vertices of the face
that lay in direct line with the source. The total incident term onto a sin-
gle surface mesh face /face is calculated according Eq. (3).
/face ¼ Einc þ
Xn
j¼1
Xm
k¼1
/scj;k ð3Þ
where n represents the number of reflections simulated and m is the total
amount of faces in the mesh. Adding the total re-emitted diffuse compo-
nent results in the fluence rate (Eq. 4).
/face;tot ¼ 1þ Rdð Þ/face ð4Þ
The diffuse reflectance coefficient Rd was calculated according to
Eq. (5) (42).
Rd ¼ a
0
2
1þ e 43ð ÞA
ffiffiffiffiffiffiffiffiffiffiffiffi
3 1a0ð Þ
ph i
e
ffiffiffiffiffiffiffiffiffiffiffiffi
3 1a0ð Þ
p
ð5Þ
where a0 ¼ l0s= l0s þ la
 
is the transport albedo and A ¼ 1þ rdð Þ=
1 rdð Þ represents the internal reflection parameter and where
rd ¼ 1:44 n2rel þ 0:71 n1rel þ 0:668þ 0:0636 nrel (43), nABS = 1.52,
nair = 1 and ntissue = 1.4 and nrel ¼ nmedium=nair are the refractive indices.
Using the obtained values for la and ls0 from the DRS measurements,
that is, ABS optical phantom, ex vivo porcine tissue and in vivo
human mucosal tissue resulted in RdABS = 0.81, Rdpor = 0.58 and
Rdtissue = 0.62. To cross-validate the reliability of the DRS measurement
results, Rdmedium was set as fit parameter in the range of Rdmedium  0.1
(0.01 interval). The simulations were run on a regular Intel CoreTM
i5-8250U CPU (8GB).
RESULTS
In the following paragraphs, the results for each specific phantom
and model are presented, including a comparison between both
developed models.
ABS optical phantoms
Empirical model. The results of the fluence rate /meas
(mWcm2) measurements at the cavity surface for three differ-
ent ABS optical phantoms, at eight different isotropic detector
locations and two light source positions are shown in Table 1.
The output power of the spherical bulb diffuser was 500 mW.
The distances between the light source and isotropic detectors
ranged from 0.6 up to 5.7 cm. All measurements located in
regions that were not directly illuminated by the spherical dif-
fuser, that is, shadow areas, were excluded from the build-up
factor b (r) analysis, since direct incident fluence rate term is
required. Note that shadow areas do however receive scatter con-
tribution from its complete surrounding area. The isotropic detec-
tors in shadow areas were digitally identified by analyzing the
3D reconstructed CBCT data. These detectors only received a
scatter contribution as shown in Table 1. By repositioning the
spherical bulb diffuser from the posterior position (P) to the ante-
rior position (A), the isotropic detector could be directly illumi-
nated in position A although not in P and vice versa.
The build-up factor was calculated according to Eq. (1) for all
valid fluence rate measurements, that is, directly illuminated by
the light source and for each phantom. The data suggest a linear
relation according to Eq. (6) between the source-detector dis-
tances and was therefore fit through the data points. It is
assumed that the build-up factor cannot be lower than 1 for
source-detector distances approaching 0.
b rð Þ ¼ ar þ 1 ð6Þ
where r is the distance between the spherical bulb diffuser and
the inner surface of the cavity. The slope is represented by a.
The linear function b (r) was fit through all available measure-
ment points, that is, n = 6, n = 8 and n = 12 for phantoms 1, 2
and 3, respectively. The slope a values were 6.0, 4.6 and 5.1 for
phantom 1, 2 and 3, respectively. Figure 4 shows the results of
all three phantoms combined.
Consequently, fitting b (r) through less data points would
result in a different value for a. To investigate the influence of
Figure 3. A rendering of half the porcine tissue phantom. Depicted is
the 3D printed shell with a Voronoi mesh structure (white) including the
porcine tissue layer secured to the inner shell by sutures. A transparent
Perspex tube was used to guide and hold the spherical diffuser in posi-
tion. Three isotropic detectors are shown as an example in this figure.
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the number of measurements n on the variance of the slope a, b
(r) was fit again using fewer data points. This was calculated for
n = 1, n = 2 and n = 3 for each phantom, for example, for the
eight available valid data points of ABS optical phantom 1
(Table 1, Fig. 5). A b (r) was fit through each unique combina-
tion of n separately, therefore resulting in maximum and mini-
mum slope a values. For example, when n = 2 for phantom 1,
all combinations of two measurements points (locations) out of
the available eight were used to fit the slope a, and therefore
resulting in the variance of slope a. Figure 5 shows the variance
of b (r) for n = 1, n = 2, n = 3 and all (n = 6) available valid
fluence rate measurements for phantom 1. Phantoms 1 and 3
demonstrated comparable results. The standard deviations (SD)
for the slope a for n = 1, 2 and 3 were 1.03, 0.56 and 0.37,
respectively. Phantom 2 and 3 showed similar results.
The more fluence rate measurements n at various distances
from the source, the more accurate the predicted values of the
empirical model will become. The fluence rate distribution over
the entire surface was calculated using the predetermined phan-
tom-specific b (r) function. The 3D simulated fluence rates that
corresponded to the location, that is, face of the isotropic detec-
tors are plotted against the actual measured fluence rate in Fig. 6
for all three ABS optical phantoms.
The slope a of the three b (r) functions was plotted as a func-
tion of the ratio between the cavities total surface areas and vol-
umes of the three surface meshes and are shown in Fig. 7. A
high surface to volume ratio is associated with increasing surface
irregularities, that is, more bulges and niches, and results in a
higher slope a value.
Analytical model. The fluence rate at the surface of ABS opti-
cal phantom 1, 2 and 3 was calculated. The total source
Table 1. Fluence rate measurements using isotropic detectors at eight different locations within the ABS optical phantoms.
Phantom
number Position
Pout
(mW)
Detector 1
(mWcm2)
Detector 2
(mWcm2)
Detector 3
(mWcm2)
Detector 4
(mWcm2)
Detector 5
(mWcm2)
Detector 6
(mWcm2)
Detector 7
(mWcm2)
Detector 8
(mWcm2)
1 A 500 85.5 30.1* 50.6 42.4* 183.4 21.7* 75.8* 70.4
1 P 500 80.0 38.1 71.4* 56.8* 115.8 18.6* 77.7* 68.4
2 A 500 209.6 118.8 156.2* 137.7* 223.4 242.6* 150.8 131.8*
2 P 500 243.1* 163.9* 183.1* 187.7* 239.1* 360.7 215.1* 185.7
3 A 500 97.6 121.9 88.4* 95.3 73.2* 54.7 60.3 15.6*
3 P 500 100.8 132.4 97.6 90.8 92.5 55.0 61.1 16.5*
The measurements have a systematic error (after calibration) of 5-10%. In the column “Position”, “A” stands for an anterior position and “P” for a poste-
rior position of the spherical bulb diffuser. The isotropic detectors that were not directly exposed to the light emanating from the source are marked with
an asterisk (*).
Figure 4. The build-up factor b (r) as a function of the source-detector
distance (r) for the three ABS optical phantoms (colored) and the porcine
phantom (black) using a spherical bulb diffuser. The visualized points in
the graph represent the build-up factor for each individual isotropic detec-
tor receiving direct incident light from the spherical bulb diffuser at dif-
ferent distances from the light source. The isotropic detectors that were
not directly illuminated by the spherical bulb diffuser, that is, the “sha-
dow areas” were excluded from the build-up factor b (r) analysis. The
measurements were performed at two different light source positions; the
“anterior” position indicated by the solid dots ● and the “posterior” posi-
tion in circles ○. The R2 values of the ABS optical phantoms were 0.91,
0.92 and 0.89 for phantoms 1, 2 and 3, respectively. The slope a of the
porcine phantom showed a value of 1.3 and R2 of the fit was 0.81.
Figure 5. Demonstrates the variance in build-up factor as a result of the
number of measuring probes used to determine b (r) for phantom 2.
“All” is the build-up function determined with all available valid fluence
rate measuring points; “n” indicates the number of measuring probes
used to determine the build-up function. These lines indicate the absolute
maximal and minimal values of the slope a of b (r) per n used measuring
probes.
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output power served as input parameter for the model
(Pout = 500mW) and corresponded to the Pout used in the flu-
ence rate experiments and the ABS optical phantoms. The dif-
fuse reflection coefficient Rd for ABS white was first
calculated according to Eq. (5) using the obtained results for
l0s and µa from the DRS measurements and resulted in an
RdABS value of 0.81. These DRS measurements are associated
with some degree of uncertainty (40,44). Rd was therefore set
as a fit parameter to match the fluence rate as measured by
all isotropic detectors (i.e. including those in the shadow
areas) to those calculated. The faces that are not in the direct
line of sight of the spherical bulb diffuser do however receive
a fraction of the total re-emitted backscattered light. The
model determines the fluence rate for these shadow areas as
opposed to the empirical model. Rd was fit in steps of 0.01
in the range of RdABS  0.1, that is, 0.7–0.9 in order to mini-
mize the root mean square (rms) between the measured flu-
ence rate and the predicted fluence rate by the analytical
model. An RdABS of 0.81 generated the best fit, with an aver-
age rms of 20.8 for all three phantoms, and was in agreement
with the RdABS as calculated according to Eq. (5). After 22
sequential reflections (Pout0:8122 ¼ Pout0:0097 ), the available
amount of energy was less than 1% of the initial amount.
This value indicates the end of the fit. Figure 8 shows the
Figure 6. The 3D empirically simulated fluence rates for all three ABS phantoms (a-c) at the mesh faces that correspond with the location of the actual
isotropic detectors plotted against the measured fluence rate. The fluence rate distribution over the entire mesh surface was calculated using the predeter-
mined phantom-specific b (r) function. The performance of each simulation is expressed in a root mean square (rms) value. The ideal line represents
/meas ¼ /sim.
Figure 7. The slope a of b (r) of the three ABS optical phantoms plot-
ted as a function of the ratio between the surface areas and volumes of
the three ABS optical phantoms.
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results for all three ABS optical phantoms including a plot of
the fits rms as function of the RdABS. In phantom 1, there are
two points that have a simulated fluence rate of zero while
the measured fluence rate is around 30–40 mWcm2. These
two points are located in a secluded sinonasal cavity that was
not directly connected to the main target location. Note that
the number of valid measurements is higher compared with
the empirical model. The analytical model is capable of calcu-
lating the fluence rate at faces who are not receiving direct
light by the light source.
Porcine tissue phantom
The results of the eight fluence rate measurements at the inner
tissue surface of the porcine tissue phantom are shown in Table 2.
The light source to isotropic detector distances were calculated
from the 3D reconstructed CBCT image data, in conjunction
with the localization of the faces that corresponded to the actual
isotropic detector positions. The distances ranged from 1.7 up to
7.2 cm.
Empirical model. First, the b (r) function was determined from
the experimental data, as shown in Fig. 4. The variances were
smaller compared with those calculated for the ABS optical
phantoms. Based on the phantom’s specific b (r), the fluence rate
distribution over the mesh surface was calculated. The simulated
fluence rate versus the measured fluence rate is shown in Fig. 9.
Analytical model. The Rd according to Eq. (5) of the porcine tis-
sue was 0.58. Rd was therefore fit around this value
(Rdpor  0.1. range 0.5–0.7) by minimizing the rms of the mea-
sured and simulated fluence rate values. An Rd of 0.62 was
obtained from the fit. The simulated fluence rate versus the mea-
sured fluence rate is shown in Fig. 9. The amount of reflections
simulated was set to 10 (Pout0:6210 ¼ 0:0084).
Model comparison
A summary of the comparison between several clinically relevant
specifications of the empirical and analytical model are shown in
Table 3.
An example of a 3D fluence rate plot and histogram of ABS
optical phantom 2 is depicted in Fig. 10 (right), an additional
histogram depicting the absolute difference (D) between the cal-
culated fluence rate per face of both models, for example, empir-
ical versus analytical, is shown on the far right. Large
differences originate from faces with a high fluence rate. The
shadow areas were not compared. The calculation time to deter-
mine the 3D fluence rate distribution for the analytical model is
fairly slow, for example, ~8 s for a given source location as
compared to 8.0 9 105 s for the empirical model.
Figure 8. The result of the analytical model for all three ABS optical phantoms (a–c). Plot (d) depicts the root mean square (rms) as a function of the
fit parameter Rd. Note that in plot (b), ABS optical phantom 2, there are two points that have a simulated fluence rate of zero while the measured flu-
ence rate is around 30–40 mWcm2. These two points are encircled with a red line and are located in a sinonasal cavity that is not directly connected
to the main target cavity.
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DISCUSSION
The primary aim of this study was to investigate the fluence rate
distribution in a complex arbitrarily shaped sinonasal cavity and
to gain insight regarding the underlying mechanisms. The results
presented are the initial results. The focus of this study was
solely on the development of fluence rate distribution models for
PDT in complex hollow geometries. The clinical response to
PDT is far more complex and includes among other things, influ-
ences of tissue oxygenation, vasculature, photosensitizer concen-
tration and the amount of reactive oxygen species. These
variables were not taken into consideration.
From the fluence rate data, an empirical model was derived.
In addition, a relatively simple analytical model was developed
to cross-validate with the empirical model using the DRS and
fluence rate results from the ABS optical phantoms as well as
the more clinically realistic porcine tissue phantom.
The fluence rate in the sinonasal cavity is determined by the
geometry and optical properties. Depending on the location of
the tumor, the original sinonasal geometry is altered by the sal-
vage surgery, varying from a (combination of) medial maxillec-
tomy, ethmoidectomy or sphenoidectomy. In addition, there is an
expected variation in optical properties within every sinonasal
cavity (33–37). A variety of tissue types are to be expected in
the sinonasal cavity after salvage surgery, such as exposed bone,
varying thickness of mucosa, scar tissue, mucus and crusts. Each
of them having different optical properties. A predictive accurate
analytical model, that is, Finite Element Method or Numerical
model (Monte Carlo Simulation) would therefore require accurate
and high spatial resolution knowledge of the local in vivo
absorption coefficient, the scattering coefficient and the scatter
function, for example, the Henyey-Greenstein phase function. In
addition, these accurate analytical and numerical models are
complex and associated with long computation times.
The tissue optical parameters vary across the surface and in
depth. These parameters are difficult to measure in vivo, requir-
ing DRS devices and multiple in vivo measurements, and are
therefore considered clinically impractical. However, these mea-
surements may deem to be necessary prior to PDT in order to
calculate the fluence rate distribution. The simpler faster models
as presented, provide the surgeon with 3D information regarding
the light dose and fluence rate distribution with an accuracy
of  25% and is considered clinically beneficial and acceptable.
The empirical model
The ABS optical phantoms, derived from actual patient CT
images accurately, mimic the geometry of sinonasal cavities. The
ABS optical properties however are homogeneously distributed
compared with an in vivo setting and equal for the three ABS
optical phantoms. The fluence rate distribution therefore only
depends on the geometry (volume, surface area and curvature/
shape) of the phantom. The larger the surface to volume ratio,
the larger slope a becomes. If the cavity surface becomes more
irregular, meaning the surface area increases as compared to the
volume, due to increasing number of bulges and niches that
Table 2. Fluence rate measurements using a spherical bulb diffuser light source at the inner surface of the porcine tissue phantom.
Position
Source
output
(mW)
Detector 1
(mWcm2)
Detector 2
(mWcm2)
Detector 3
(mWcm2)
Detector 4
(mWcm2)
Detector 5
(mWcm2)
Detector 6
(mWcm2)
Detector 7
(mWcm2)
Detector 8
(mWcm2)
A 1500 129.7 35.3 28.1 20.3 12.7 4.7 7.5 107.2
P 1500 96.8 11.4 73.3 45.9 45.8 15.8 29.7 130.5
In column “Position,” “A” stands for an anterior position and “P” for a posterior position of the light source.
Figure 9. Based on the porcine tissue phantom-specific b (r), the fluence
rate distribution over the entire mesh surface was calculated with the empir-
ical and analytical models. This plot shows the simulated fluence rate ver-
sus the measured fluence rate at the actual location of the isotropic detector.
Table 3. A comparison between both developed models.
Subject Empiric model Analytic model
Calculation speed
(ABS optical
phantom—porcine
tissue phantom)
Fast (8.0 9 105–
8.0 9 105 s)
Slow (15.9–7.9 s)
Rms (ABS optical
phantom—porcine
tissue phantom)
27.5–7.4 20.8–8.2
Variables b (r) Rd
Requirements to
perform calculations
Fluence rate(s)
measurements at
known source
detectors distance.
CT imaging.
A measurement of la,
ls0 or Rd direct.
CT imaging.
Shadow
determination
Estimated Feasible
Pitfalls Linear assumption of
b (r) through (0,1).
Simplistic ray tracing
algorithm and inverse
square law usage for
large faces relative to
the distance between
source and face.
Clinical applicability Easier to implement Harder to implement
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result from surgery, the slope will increase as shown in Fig. 7.
This observation implies that slope a could potentially be derived
from CT data, provided that the global optical properties are
known and comparable between patients. In order to demonstrate
this concept, additional in vivo fluence rate data with known
source-detector distances are required.
The reduced scattering coefficient of the ABS material was
determined by DRS measurements and comparable to that of
in vivo mucosal tissue (8.6 cm1 vs 12.8 cm1) and porcine tis-
sue (8.6 cm1 vs 10.4 cm1). The ABS white absorption coeffi-
cient however was a factor of ~ 13 lower than in vivo mucosal
tissue (0.01 cm1 for ABS white vs 0.13 cm1 for porcine tis-
sue). This will result in a higher fluence rate build-up factor in
the ABS optical phantom as compared to the porcine tissue
phantom or in a clinical setting. The average b (r) slope a of the
ABS optical phantom was 5.2 compared to the slope of 1.3 for
the porcine tissue model. This would imply that for even higher
absorption, that is, increasing blood content, the slope of the b
(r) approximates 1. The scatter contribution would consequently
become independent of the distance between the light source and
the inner tissue surface and could therefore be considered con-
stant.
The values of the build-up factors b at the surface of the por-
cine tissue range between 3 and 4 for source to isotropic detector
distances between ~1.5 and 2.5 cm. The b values for Barrett’s
esophagus ranged between 1.2 and 4 at a distance of 12.5 mm,
and comparable results were demonstrated in the nasopharynx,
that is, 1 and 4.4 (10,20,30). Hemoglobin is the dominant
absorption chromophore in tissue at a wavelength of 652 nm.
The build-up factor for ex vivo porcine is expected to be higher
as a result of a low hemoglobin content.
The accuracy for both models was higher for the porcine
phantom as compared to the ABS optical phantoms. Although
the optical properties of porcine tissue are less homogeneously
distributed, the shape of the geometry was less irregular (surface
to volume ratio of 1.63) as compared to the ABS phantoms, this
may contribute in a higher accuracy.
Zhu et al. developed an intracavity model to simulate and
measure the fluence rate distribution at the pleural surface during
cavity PDT of malignant mesothelioma (28,32). They incorpo-
rated a time-dependent correction factor and a constant scatter
contribution that is independent of the shape of the lung cavity,
to match the detector readings into their model. The pleural cav-
ity is ellipsoidal in shape and illuminated directly after surgery.
The tissue surface will therefore be dark reddish in color. If the
proposed empirical model would be employed, the value for
slope a would be low and the scatter contribution could accord-
ingly considered to be constant. In addition, the light source is
positioned centrally in the pleural cavity, which means that in
these well-defined geometries the differences in distances
between the light source and the detectors are relatively similar.
The proposed models should generate reliable fluence rate distri-
bution maps in case of PDT of the pleural cavity provided that
the correct b (r) or Rd is employed.
Foscan–mediated PDT of sinonasal malignancies is per-
formed with a time interval of at least six weeks after surgery.
This time interval was incorporated to allow the tissue to heal
(i.e. the tissue vascular perfusion) and to have as little extravas-
cular blood as possible in the cavity during the illumination.
Besides, to minimize a surgical stress response resulting in
increased cytokine release which might negatively influence the
PDT effect (22). Extravascular blood shields the therapeutic light
Figure 10. An example of a 3D mesh fluence rate plot of the ABS optical phantom 2 generated by the empirical model (sagittal view). On the left, the
corresponding fluence rate distribution-face histogram. The source output power was set at 1500 mW. The source position was the same for both mod-
els. On the right, the false-color scale of the fluence rate ranging from 0 (blue) op to 1000 mWcm2 (red). The histogram on the right shows the abso-
lute difference per face between both models.
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from entering the tissue and is therefore expected to compromise
the PDT effect. Note that for pleural malignant mesothelioma
PDT, a six-week interval between surgery and PDT is clinically
not feasible.
The sinonasal cavity is arbitrary in shape and size, which
results in relatively large distances between the light source and
isotropic detectors, and is expected to have a higher build-up fac-
tor due to the healed tissue. A b (r) build-up function should, for
this particular PDT application, be incorporated.
As seen in Fig. 4, the experimental fluence rate data are fit
with a simple linear function and intersect through coordinate
(0,1). The assumption of an intersection at r = 0, b = 1 may not
be fully accurate. If the spherical bulb diffuser is positioned close
to the tissue, there will always be the local fluence rate re-emit-
tance term (/bsc), which in turn depends on Rd. Rd + 1, is
expected to range from 1 to < 2. This intersection uncertainty
will be investigated in future studies. In addition, the exact b (r)
function is more likely to be a r2 + b. To confirm this assump-
tion, an analytical derivation for b (r) and additional experimen-
tal fluence rate data for close source/surface distances are
necessary.
When moving the light source closer to the tissue surface, the
scatter contribution /sc and Einc are expected to increase with 1/
r2, resulting in a decrease in the build-up factor value at close
source-surface distances. If the source is positioned in the vicin-
ity of the center of the cavity, the scatter contribution to the sur-
face will decrease less compared to the direct incident term Einc,
resulting in an increase in the build-up factor. In addition, small
off-center source positions will be of limited influence on b (r).
When the Rd of the tissue decreases, for example, in case of
higher blood absorption, the slope a of the build-up factor func-
tion will decrease, and thus the scatter contribution to the total
fluence rate at the tissue surface will become less.
The predictive power of the empirical model clearly depends
on the number of fluence rate measurements used to determine
the b function. One measurement at given known distance at a
random location and one intersection point will result in a larger
uncertainty in slope a resulting in a less reliable predictive
power. Multiple fluence rate measurements at random locations
(at different distances) however will result in a more reliable pre-
diction. In a clinical setting, it would be feasible to measure this
prior to PDT in order to predict the fluence rate in the total treat-
ment geometry. A dedicated applicator to measure the fluence
rate at least at two different fixed distances is currently under
development. An example of such an applicator was demon-
strated by Murrer et al. (45).
The analytical model
The model employs radiometric equations together with diffuse
Lambertian re-emitting surfaces and does not take (multiple)
specular reflections in consideration as expected in a mucosal tis-
sue cavity. The main drawback of the analytic model, if consid-
ered as a clinically potential fluence rate prediction model, is that
the actual patient-specific global Rd value is unknown. Determin-
ing the Rd of the three ABS optical phantoms and the porcine
tissue phantom was achieved by fitting the simulation data to the
measured data to achieve a minimal rms, by either increasing or
decreasing Rd in steps of 0.01. The fit values for the Rd yielded
0.81 for ABS white, and for porcine tissue 0.58, respectively.
The theoretical values of Rd according to Eq. (2) using ls0 and
la of the DRS measurements and nrel from literature resulted in
an RdABS = 0.81 and Rdpor = 0.62, respectively, and are in close
agreement with those resulting from the fluence rate fit result.
Beck et al. measured a total diffuse reflectance Rd of in vivo
bladder tissue of 0.59 (46). The DRS measurements on oral buc-
cal mucosal tissue resulted in Rdmucosal of 0.62. The results
clearly demonstrate the reliability of the analytical model. If the
analytical model would be employed in a clinical setting, a series
(on the various tissue types present in the sinonasal cavity) of
diffuse reflectance measurements would be required in order to
determine a global value for Rdtissue.
The analytical model calculates a 3D fluence rate distribution
map in ~16 s for a single source location (see Table 3). To find
the OSL, all possible source locations within the sinonasal cavity
are required for calculation. The future goal is to use an electro-
magnetic navigation device with a one-millimeter spatial accu-
racy to guide the light source to the OSL. This implies that, in
case of a sinonasal cavity, an estimation of ~10,000 possible
source locations need to be calculated in order to find the OSL
for a single source. An efficient and fast cost function in combi-
nation with GPU computing is therefore necessary and currently
being investigated. The planning is carried out prior to the PDT
and therefore requires no extra time during the actual PDT treat-
ment.
In conclusion, the predictive value of the empirical and ana-
lytical model is ~20% accurate for both types of phantoms used
and was even less than 10% for the porcine tissue phantom. The
presented models may generate less accurate fluence rate data in
an optically inhomogeneous environment as endoscopically
observed in vivo during sinonasal PDT. However, it still provides
valuable estimated information on how the light will be dis-
tributed within the sinonasal cavity in 3D in these complex
geometries, and where necrosis is likely to be expected for a
given source location and output power. Table 3 suggests that
repositioning the source during PDT could be employed for an
improved illumination of the target area as compared to a single
source position. An algorithm, for example, differential evolu-
tion, that determines one or multiple OSL’s with varying output
power, in order to achieve the most effective illumination at the
target area, while limiting the dose delivered to the organs at risk
is therefore currently under construction. This algorithm will
generate the coordinates for the optimal source position that will
be transferred to an electromagnetic (EM) navigation system,
which helps the surgeon to guide the spherical bulb diffuser to
the OSL. Baran et al. investigated intracavity PDT of deep-seated
drained abscesses with complex geometries (47). The light distri-
bution was calculated by means of Monte Carlo (MC) simula-
tions. The delivery was performed with a bare cleaved fiber
placed in the center of the volume. Their goal was to determine
the optical power at which a fluence rate of 4 or 20 mW cm2
was achieved at 95% of the abscess wall. They showed that
abscesses with a smaller surface are more amenable compared to
abscesses with a larger surface. In case of sinonasal PDT, only
the cavities region with residual or recurrent tumor require an
effective fluence of 18–22 mW cm2. Potential adjacent organs
like the brain, optical nerves and carotid arteries should not
exceed a fluence over 5 mW cm2. Additional research will be
conducted regarding: (1) the determination of Rd from postopera-
tive in vivo sinonasal tissue ls0 and la measurements by means
of multidiameter single fiber reflectance spectroscopy (MDSFR),
(2) the effect of the surface to volume ratio and optical properties
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on the b (r) function, (3) the incorporation of a microlens and
linear diffuser source into the model and (4) the development of
applicators that allow for multiple fluence rate measurements at
known source-detector distances.
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